Enliven Therapeutics
ELVN
ELVN
33 hedge funds and large institutions have $257M invested in Enliven Therapeutics in 2020 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 23 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.54% more ownership
Funds ownership: 16.2% → 16.74% (+0.54%)
Holders
33
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.97M | |
| 2 | +$2.32M | |
| 3 | +$1.33M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$911K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$467K |
Top Sellers
| 1 | -$483K | |
| 2 | -$249K | |
| 3 | -$134K | |
| 4 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
-$71.7K |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$20.6K |